Clinical Trial Update: Dose-ranging Study of SPL7013 Gel for the Prevention of Bacterial Vaginosis (BV) [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 dose-ranging study evaluating SPL7013 Gel for the prevention of recurrent bacterial vaginosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• SPL7013 Gel (SPL7013)

Snippet

Sponsor: Starpharma Pty Ltd | Conditions: Recurrent Bacterial Vaginosis (BV) | Phase 2 | Status: COMPLETED